NASDAQ:XERS

Xeris Pharmaceuticals Stock Predictions

etoro logo Buy XERS
*Your capital is at risk
$5.89
-0.110 (-1.83%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

XERS Prediction Chart

XERS Predictions History

Latest community submissions for XERS.
Predictor Target Session Target Price Result Direction Accuracy Score
Aug 14, 2025 $7.21 -0.92% $7.30 X 98.81% 1
Aug 14, 2025 Bullish $7.30 X 1
Aug 12, 2025 $7.05 -2.08% $7.30 X 96.58% 0
Aug 12, 2025 $7.11 -1.30% $7.30 X 97.35% 0
Aug 12, 2025 Bullish $7.30 V 1
Aug 11, 2025 $6.76 -1.24% $7.20 X 93.82% 0
Aug 11, 2025 Bullish $7.20 V 1
Jul 29, 2025 $5.12 +1.01% $5.00 X 97.58% 0
Jul 29, 2025 Bullish $5.00 X 0
Jul 28, 2025 $5.10 +1.67% $5.07 V 99.33% 4
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for XERS with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT XERIS PHARMACEUTICALS INC
Xeris Pharmaceuticals
Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, hypokalemic, and related variants of primary periodic paralysis; and Recorlev, a cortisol synthesis inhi...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE